Lv1
30 积分 2020-10-05 加入
Azo-based hypoxic-activated 6-diazo-5-oxo-L-norleucine (DON) prodrug combined with vascular disrupting agent nanoparticles for tumor-selective glutamine metabolism blockade
5小时前
待确认
Immunotherapy in hepatocellular cancer
3年前
已完结
Self-Amplifying Nanotherapeutic Drugs Homing to Tumors in a Manner of Chain Reaction
4年前
已完结
HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer
4年前
已完结
皖公网安备34019202002308
